Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Extension to Share Buyback Programme

12 Aug 2024 07:00

RNS Number : 9876Z
Crystal Amber Fund Limited
12 August 2024
 

 

 

12 August 2024

 

Crystal Amber Fund Limited

("Crystal Amber Fund", the "Company" or the "Fund")

 

Extension to Share Buyback Programme

 

Crystal Amber Fund announces that it will continue its share buyback programme for the period to 31 October 2024. Since 8 December 2023, £8.4 million has now been utilised in the programme for the period and from now until to 31 October 2024 the Company intends to continue to conduct on-market purchases under the share buyback programme to repurchase ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") up to an aggregate amount of £1.6 million, pursuant to the authority obtained at the Company's annual general meeting on 22 November 2023 (the "Buyback").

 

The Company has appointed Winterflood Securities Limited ("Winterflood") to execute and manage the Buyback and has given an irrevocable instruction to Winterflood to make market purchases of Ordinary Shares on its behalf, independently of the Company. Winterflood will make its trading decisions in relation to the Ordinary Shares independently of and uninfluenced by the Company with such trading decisions being in line with the terms of the Buyback.

 

The maximum price which may be paid by the Company per Ordinary Share shall not be more than the higher of:

a.  105 per cent of the average of the middle market quotations for an Ordinary Share as derived from the AIM market of the London Stock Exchange plc for the five business days immediately preceding the day on which the purchase is made; and

b. the value of an Ordinary Share calculated on the basis of the higher of the price quoted for (i) the last independent trade of and (ii) the highest current independent bid for the Ordinary Shares.

 

The Company has determined that it will not rely on the safe harbour conditions for trading set out in Article 5 of EU Market Abuse Regulation (2014/596/EU) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR") and, accordingly, the Company will not benefit from the exemption contained in Article 5 of UK MAR, given the limited liquidity in the Ordinary Shares and limitations that it would impose on the number of Ordinary Shares that can be purchased. Therefore, the Company may purchase Ordinary Shares pursuant to the Buyback on any trading day materially in excess of 25 per cent of the average daily volume in the 20 trading days preceding the date on which the purchase is carried out, being the limit laid down in Article 5(1) of UK MAR.

 

There is no guarantee that the Buyback programme will be implemented in full or that any purchases will be made. The Company reserves the right to bring a halt to the Buyback under circumstances that it deems to be appropriate and in accordance with relevant law and regulation.

 

The Company will make further announcements in due course following any share purchases conducted through the Buyback.

 

 

For further enquiries please contact:

 

Crystal Amber Fund Limited

Chris Waldron (Chairman)

Tel: 01481 742 742

www.crystalamber.com

 

Allenby Capital Limited - Nominated Adviser

Jeremy Porter/ Dan Dearden-Williams

Tel: 020 3328 5656

 

Winterflood Investment Trusts - Broker

Joe Winkley/Neil Langford

Tel: 020 3100 0160

 

Crystal Amber Advisers (UK) LLP - Investment Adviser

Richard Bernstein

Tel: 020 7478 9080

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFIITLILLIS
Date   Source Headline
22nd May 20261:07 pmRNSMonthly Net Asset Value
6th May 202612:54 pmRNSPurchase of Ordinary Shares by Tarncourt
30th Apr 20265:00 pmRNSTotal Voting Rights
22nd Apr 20262:54 pmRNSMonthly Net Asset Value
22nd Apr 20269:47 amRNSResult of EGM
16th Apr 20265:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20265:03 pmRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202610:51 amRNSTransaction in Own Shares and Total Voting Rights
1st Apr 20265:41 pmRNSDirector/PDMR Shareholding
31st Mar 20265:00 pmRNSTotal Voting Rights
31st Mar 20267:01 amRNSHalf-year Report
31st Mar 20267:00 amRNSPosting of Circular and Notice of EGM
26th Mar 20264:25 pmRNSMonthly Net Asset Value
16th Mar 20264:29 pmRNSNotice of results; update re strategy and manager
2nd Mar 202611:49 amRNSMonthly Net Asset Value
2nd Mar 202611:30 amRNSTotal Voting Rights
25th Feb 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
24th Feb 20265:26 pmRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20265:44 pmRNSTransaction in Own Shares and Total Voting Rights
18th Feb 20265:04 pmRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20264:04 pmRNSUpdate on Morphic Medical Inc.
13th Feb 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20264:58 pmRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20265:02 pmRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20265:29 pmRNSTransaction in Own Shares and Total Voting Rights
9th Feb 20265:40 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20266:24 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20265:59 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20266:20 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20265:30 pmRNSTotal Voting Rights
29th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
29th Jan 202610:38 amRNSMonthly Net Asset Value
27th Jan 20269:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jan 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:32 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:18 pmRNSReplacement: Update and corrections regarding TVRs
16th Jan 20267:00 amRNSReplacement: Transaction in Own Shares and TVR
16th Jan 20267:00 amRNSUpdate & corrections regarding total voting rights
12th Jan 20265:46 pmRNSCancellation of treasury shares
6th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20265:31 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.